Pattern of Rash, Diarrhea, and Hepatic Toxicities Secondary to Lapatinib and Their Association With Age and Response to Neoadjuvant Therapy: Analysis From the NeoALTTO Trial

201363 citationsJournal Articlebronze Open Access

Authors

Our results indicate that the frequency and clinical relevance of lapatinib-related rash is largely dependent on patient age.

Good health and well-being

Published in: Journal of Clinical Oncology

Volume 31, Issue 36, pp. 4504-4511

Field-Weighted Citation Impact: 5.50